Skip to Main Content

GSK plc American Depositary Shares (Each representing two

GSK Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
GSK Income Statement
GSK Balance Sheet
GSK Cash Flow

Recent trades of GSK by members of U.S. Congress

Politician Type Traded
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Nov. 25, 2024
Tommy Tuberville Senate / R Sale (Full) $1,001 - $15,000 Oct. 16, 2023
Daniel S. Goldman House / D Sale $15,001 - $50,000 Jul. 10, 2023
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Apr. 03, 2023
Virginia Foxx House / R Sale $50,001 - $100,000 Mar. 01, 2023
Virginia Foxx House / R Purchase $1,001 - $15,000 Aug. 16, 2022
Virginia Foxx House / R Purchase $15,001 - $50,000 Aug. 10, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Aug. 09, 2022
Virginia Foxx House / R Purchase $15,001 - $50,000 Aug. 05, 2022
Virginia Foxx House / R Sale $100,001 - $250,000 Jul. 12, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Jul. 06, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Apr. 08, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Feb. 22, 2022
John H. Rutherford House / R Sale $1,001 - $15,000 Feb. 17, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Jan. 14, 2022
Virginia Foxx House / R Purchase $1,001 - $15,000 Oct. 08, 2021
Virginia Foxx House / R Purchase $1,001 - $15,000 Jul. 09, 2021
Katherine M. Clark House / D Sale $1,001 - $15,000 Jun. 04, 2021
Katherine M. Clark House / D Sale $1,001 - $15,000 Jun. 04, 2021
Virginia Foxx House / R Purchase $1,001 - $15,000 Apr. 09, 2021
Virginia Foxx House / R Purchase $1,001 - $15,000 Jan. 15, 2021
Katherine M. Clark House / D Purchase $1,001 - $15,000 Nov. 05, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Nov. 05, 2020
Katherine M. Clark House / D Sale $1,001 - $15,000 Oct. 22, 2020
Katherine M. Clark House / D Sale $1,001 - $15,000 Oct. 22, 2020
Virginia Foxx House / R Purchase $1,001 - $15,000 Oct. 09, 2020
Virginia Foxx House / R Purchase $1,001 - $15,000 Jul. 10, 2020
Virginia Foxx House / R Purchase $15,001 - $50,000 Apr. 13, 2020
Greg Gianforte House / R Purchase $50,001 - $100,000 Mar. 18, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Mar. 02, 2020
Katherine M. Clark House / D Purchase $1,001 - $15,000 Mar. 02, 2020
Virginia Foxx House / R Purchase $1,001 - $15,000 Jan. 10, 2020
Virginia Foxx House / R Purchase $1,001 - $15,000 Oct. 11, 2019
Virginia Foxx House / R Purchase $1,001 - $15,000 Jul. 12, 2019
Virginia Foxx House / R Purchase $1,001 - $15,000 Apr. 12, 2019
Nicholas V. Taylor House / R Sale $15,001 - $50,000 Mar. 25, 2019
Nicholas V. Taylor House / R Sale $15,001 - $50,000 Mar. 25, 2019
Virginia Foxx House / R Purchase $1,001 - $15,000 Jan. 10, 2019
Greg Gianforte House / R Sale $15,001 - $50,000 Dec. 21, 2018
Virginia Foxx House / R Purchase $15,001 - $50,000 Dec. 11, 2018
Virginia Foxx House / R Purchase $1,001 - $15,000 Oct. 09, 2018
Zoe Lofgren House / D Sale $1,001 - $15,000 Aug. 30, 2018
Virginia Foxx House / R Purchase $1,001 - $15,000 Apr. 12, 2018
Greg Gianforte House / R Purchase $1,001 - $15,000 Mar. 26, 2018
Katherine M. Clark House / D Sale $1,001 - $15,000 Jan. 03, 2018
Katherine M. Clark House / D Sale $1,001 - $15,000 Jan. 03, 2018
Greg Gianforte House / R Sale $50,001 - $100,000 Dec. 14, 2017
Ken Buck House / R Sale $1,001 - $15,000 Nov. 07, 2017
Ken Buck House / R Purchase $1,001 - $15,000 Oct. 27, 2017
Pete Sessions House / R Purchase $1,001 - $15,000 Oct. 25, 2017
GSK Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GSK Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GSK Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by GSK's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Blister package apparatus and methods for tablets May. 21, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GSK in WallStreetBets Daily Discussion

GSK News

Recent insights relating to GSK

CNBC Recommendations

Recent picks made for GSK stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GSK

GSK Top Shareholders
Shareholder
Shares Held
GSK Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GSK Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GSK Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top